Clinical trial
68Ga-FAPI PET Imaging in Malignancy
NCT04023240 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 68Ga-FAPI PET Imaging in Malignancy
- Lead sponsor
- Stanford University
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- July 31, 2023
- Completion date
- December 14, 2023
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer